Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Chabala

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Biotechnology|December 1, 1995
Solid-phase combinatorial chemistry and novel tagging methods for identifying leadsJ C Chabala
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factorS B Hwang, M H Lam, A W Alberts, et al.
Biochemical and Biophysical Research Communications|August 30, 1989
The inhibition of cytoplasmic acetoacetyl-CoA thiolase by a triyne carbonate (L-660, 631)M D Greenspan, J B Yudkovitz, J S Chen, et al.
Experientia|January 15, 1991
1-(substituted)benzyl-5-aminoimidazole-4-carboxamides are potent orally active inhibitors of Trypanosoma cruzi in miceJ C Chabala, V B Waits, T Ikeler, et al.
Journal of Medicinal Chemistry|September 1, 1991
Benzylated 1,2,3-triazoles as anticoccidiostatsR J Bochis, J C Chabala, E Harris, et al.
Journal of Lipid Mediators|June 1, 1993
MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factorS B Hwang, M H Lam, D M Szalkowski, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1991
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeysK L Thomson, M N Chang, R L Bugianesi, et al.
Biochemical and Biophysical Research Communications|February 15, 1988
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.
Journal of Medicinal Chemistry|September 18, 1992
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.
Journal of Medicinal Chemistry|October 1, 1980
Ivermectin, a new broad-spectrum antiparasitic agentJ C Chabala, H Mrozik, R L Tolman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Biotechnology|December 1, 1995
Solid-phase combinatorial chemistry and novel tagging methods for identifying leadsJ C Chabala
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1988
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factorS B Hwang, M H Lam, A W Alberts, et al.
Biochemical and Biophysical Research Communications|August 30, 1989
The inhibition of cytoplasmic acetoacetyl-CoA thiolase by a triyne carbonate (L-660, 631)M D Greenspan, J B Yudkovitz, J S Chen, et al.
Experientia|January 15, 1991
1-(substituted)benzyl-5-aminoimidazole-4-carboxamides are potent orally active inhibitors of Trypanosoma cruzi in miceJ C Chabala, V B Waits, T Ikeler, et al.
Journal of Medicinal Chemistry|September 1, 1991
Benzylated 1,2,3-triazoles as anticoccidiostatsR J Bochis, J C Chabala, E Harris, et al.
Journal of Lipid Mediators|June 1, 1993
MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factorS B Hwang, M H Lam, D M Szalkowski, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1991
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeysK L Thomson, M N Chang, R L Bugianesi, et al.
Biochemical and Biophysical Research Communications|February 15, 1988
(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.
Journal of Medicinal Chemistry|September 18, 1992
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.
Journal of Medicinal Chemistry|October 1, 1980
Ivermectin, a new broad-spectrum antiparasitic agentJ C Chabala, H Mrozik, R L Tolman, et al.
Pageof 2